Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Rowe

Showing results (251-260 of 504) with videos related to

Pageof 51
Sort By:
Journal of the American College of Radiology : JACR|January 21, 2026
Reclosing Pandora's Box? Strategies to Mitigate Increased Workload Generated by Immediate Patient Access to Radiology ReportsSteven P Rowe, Jason Chandrapal, Kristen H Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2020
Measurement of PET Quantitative Bias In VivoMartin A Lodge, Wojciech Lesniak, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2016
Whole-Body <sup>18</sup>F-FDG PET and <sup>18</sup>F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic AccuracySara Sheikhbahaei, Charles V Marcus, Roberto S Fragomeni, et al.
World Journal of Nuclear Medicine|January 15, 2020
Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted <sup>18</sup>F-DCFPyL positron emission tomography/computed tomography: A unique visual patternYafu Yin, Channing J Paller, Martin G Pomper, et al.
AJR. American Journal of Roentgenology|November 18, 2020
Role of <sup>18</sup>F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: <i>AJR</i> Expert Panel Narrative ReviewBital Savir-Baruch, Peter L Choyke, Steven P Rowe, et al.
Cold Spring Harbor Molecular Case Studies|July 2, 2021
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastomaTingting Liu, Matthew D Merguerian, Steven P Rowe, et al.
Tomography (Ann Arbor, Mich.)|December 28, 2020
Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold NanoparticlesMrudula Pullambhatla, Steven P Rowe, Ala Lisok, et al.
AJR. American Journal of Roentgenology|October 6, 2021
Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the <i>AJR</i> Special Series on Imaging of InflammationSara Sheikhbahaei, Charles V Marcus, Mohammad S Sadaghiani, et al.
Journal of the American College of Radiology : JACR|April 12, 2026
How to Rebrand Academic Radiology. Reply to: Saving Academic Radiology: Summary of the 2025 ACR Intersociety MeetingSalma Hassenein, Erin N Gomez, Linda C Chu, et al.
Journal of the American College of Radiology : JACR|May 28, 2019
From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal TrialsRudolf A Werner, Brent Savoie, Mehrbod S Javadi, et al.
Pageof 51

Showing results (251-260 of 504) with videos related to

Sort By:
Pageof 51
Journal of the American College of Radiology : JACR|January 21, 2026
Reclosing Pandora's Box? Strategies to Mitigate Increased Workload Generated by Immediate Patient Access to Radiology ReportsSteven P Rowe, Jason Chandrapal, Kristen H Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2020
Measurement of PET Quantitative Bias In VivoMartin A Lodge, Wojciech Lesniak, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2016
Whole-Body <sup>18</sup>F-FDG PET and <sup>18</sup>F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic AccuracySara Sheikhbahaei, Charles V Marcus, Roberto S Fragomeni, et al.
World Journal of Nuclear Medicine|January 15, 2020
Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted <sup>18</sup>F-DCFPyL positron emission tomography/computed tomography: A unique visual patternYafu Yin, Channing J Paller, Martin G Pomper, et al.
AJR. American Journal of Roentgenology|November 18, 2020
Role of <sup>18</sup>F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: <i>AJR</i> Expert Panel Narrative ReviewBital Savir-Baruch, Peter L Choyke, Steven P Rowe, et al.
Cold Spring Harbor Molecular Case Studies|July 2, 2021
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastomaTingting Liu, Matthew D Merguerian, Steven P Rowe, et al.
Tomography (Ann Arbor, Mich.)|December 28, 2020
Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold NanoparticlesMrudula Pullambhatla, Steven P Rowe, Ala Lisok, et al.
AJR. American Journal of Roentgenology|October 6, 2021
Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the <i>AJR</i> Special Series on Imaging of InflammationSara Sheikhbahaei, Charles V Marcus, Mohammad S Sadaghiani, et al.
Journal of the American College of Radiology : JACR|April 12, 2026
How to Rebrand Academic Radiology. Reply to: Saving Academic Radiology: Summary of the 2025 ACR Intersociety MeetingSalma Hassenein, Erin N Gomez, Linda C Chu, et al.
Journal of the American College of Radiology : JACR|May 28, 2019
From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal TrialsRudolf A Werner, Brent Savoie, Mehrbod S Javadi, et al.
Pageof 51